Imidazopyrazine Derivatives As Inhibitors of mTOR

被引：1
|
作者：
Rosse, Gerard [1 ,2 ]
机构：
[1] Dart Neurosci LLC, Struct Guided Chem, San Diego, CA 92121 USA
[2] Drexel Univ, Coll Med, Dept Physiol & Pharmacol, Philadelphia, PA 19102 USA
来源：
ACS MEDICINAL CHEMISTRY LETTERS | 2013年 / 4卷 / 06期
关键词：
D O I：
10.1021/ml400139e
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
引用
收藏
页码：498 / 499
页数：2
相关论文
共 50 条
  • [41] Overview of Research into mTOR Inhibitors
    Mao, Beibei
    Zhang, Qi
    Ma, Li
    Zhao, Dong-Sheng
    Zhao, Pan
    Yan, Peizheng
    MOLECULES, 2022, 27 (16):
  • [42] Pharmacodynamic Monitoring of mTOR Inhibitors
    Millan, Olga
    Wieland, Eberhard
    Marquet, Pierre
    Brunet, Merce
    THERAPEUTIC DRUG MONITORING, 2019, 41 (02) : 160 - 167
  • [43] Research progress of mTOR inhibitors
    Chen, Yifan
    Zhou, Xiaoping
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2020, 208
  • [44] Mechanism of mTOR inhibitors activity
    Wysocki, Piotr J.
    ONCOLOGY IN CLINICAL PRACTICE, 2009, 5 : C3 - C11
  • [45] Mechanisms of resistance to mTOR inhibitors
    Berns, K.
    Bernards, R.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : S104 - S104
  • [46] The pleiotropic effects of mTOR inhibitors
    Ponticelli, C
    JOURNAL OF NEPHROLOGY, 2004, 17 (06) : 762 - 768
  • [47] Inhibitors of mTOR in aging and cancer
    Zhavoronkov, Alexander
    ONCOTARGET, 2015, 6 (42): : 45010 - 45011
  • [48] mTOR signaling pathway and mTOR inhibitors in cancer: progress and challenges
    Zou, Zhilin
    Tao, Tao
    Li, Hongmei
    Zhu, Xiao
    CELL AND BIOSCIENCE, 2020, 10 (01):
  • [49] mTOR signaling pathway and mTOR inhibitors in cancer: progress and challenges
    Zhilin Zou
    Tao Tao
    Hongmei Li
    Xiao Zhu
    Cell & Bioscience, 10
  • [50] Targeting mTOR for fighting diseases: A revisited review of mTOR inhibitors
    Xu, Tian
    Sun, Dejuan
    Chen, Yi
    Ouyang, Liang
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2020, 199
12345